Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma
Shogo Shigeta(Tohoku University), Christopher J. Kemp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 30
Related Papers
p19 Arf Suppresses Growth, Progression, and Metastasis of Hras-Driven Carcinomas through p53-Dependent and -Independent Pathways
|PLoS Biology|2004|81
Synergy between Prkdc and Trp53 regulates stem cell proliferation and GI-ARS after irradiation
|Cell Death and Differentiation|2017|25
MicroRNA-152 Regulates Endometrial Serous Carcinoma Cell Motility by Suppressing Matrix Metalloproteinase 10 Expression
|The Tohoku Journal of Experimental Medicine|2022|3